New Investors to Support Expansion of the Platform into Europe, Private Credit and Data Analytics

NEW YORK, April 30, 2026 — Versana today announced the close of a $43 million capital raise led by BNP Paribas, with new strategic investments from Fitch Ventures, MassMutual Ventures, Motive Partners and Apollo. Existing shareholders Bank of America, Barclays, Citi, Deutsche Bank, J.P. Morgan, Morgan Stanley, U.S. Bancorp and Wells Fargo also made follow-on investments in continued support of the company’s future growth. With this latest financing, Versana has raised over $125 million across multiple funding rounds, further advancing the digital transformation of the $9 trillion broadly syndicated loan (BSL) and private credit markets.

Lead investor BNP Paribas has made a strategic investment in the platform, further supporting Versana’s continued global expansion and growth. This investment underscores the increasing demand for modern digital infrastructure across the loan markets and reinforces Versana’s position as a leading industry platform.

Fitch Ventures, the corporate venture arm of Fitch Group, a leading provider of credit ratings, market research, data and analytics, has joined Versana as a key strategic investor to help expand its product-market fit into the pre-trade, credit decision-making process valued by portfolio managers and credit analysts.

Apollo joins as a strategic investor, supporting the continued expansion of Versana’s capabilities across its product suite. In addition, Apollo’s participation further strengthens Versana’s connectivity with the buyside and advances the digital innovation of the loan market ecosystem.

“We’re thrilled that BNP Paribas, Fitch Ventures, MassMutual Ventures, Motive Partners and Apollo have joined as strategic financing partners,” said Cynthia Sachs, Founding CEO of Versana. “This is truly a landmark moment, reflecting clear alignment across two very similar asset classes, BSL and private credit, and the need for modern digital infrastructure and data on one centralized platform. Together, with ongoing support from our existing investors, these new commitments strengthen our global position to accelerate platform growth, product innovation and digital data expansion.”

Commentary from New Investors:

“BNP Paribas is proud to lead this investment and join Versana as a strategic partner,” said Matthew Salvner, Head of Global Banking Americas at BNP Paribas. “Versana is digitally transforming the broadly syndicated loan market at scale in the U.S. and Europe, and we look forward to working with our peers to accelerate the modernization of these global loan markets.”

“Fitch is excited to partner with Versana to support greater efficiency and transparency in the broadly syndicated loan market,” said Steven Miller, Managing Director at Fitch. “We see meaningful opportunity to connect our complementary datasets to provide a more comprehensive and consistent view across loan data, including books and records, terms and conditions, covenants and related commentary.”

“MassMutual Ventures is pleased to back Versana as an investor, building on Barings’ relationship with Versana as a subscriber,” said Eric Emmons, Managing Partner at MassMutual Ventures. “As BSL and private credit continue to scale, the need for accurate, standardized, accessible and transparent real-time data has never been greater. Versana is well-positioned to meet this need, and we support the continued evolution of the asset class.”

“We believe in Versana’s mission to modernize the broadly syndicated loan market,” said Jennifer Lin, Managing Director at Apollo. “Improving transparency and efficiency in BSL operations is important for the entire market, and we look forward to partnering with Versana as the platform continues to grow.”

This capital raise underscores Versana’s continued momentum to digitally modernize the global loan markets. In 2025, the company introduced its Versana Reconciliation Module and a first-of-its-kind cashless roll solution linking an amended facility to its original facility. Active facility coverage now exceeds $4.1 trillion in notional value, demonstrating Versana’s progress and reinforcing its commitment to transform the investment-grade and leveraged loan markets.

About Versana

Versana is an industry-backed enterprise data and digital infrastructure company transforming the broadly syndicated loan and private credit markets. By digitally capturing agents’ loan data on a real-time basis from golden-source ledgers, Versana provides unprecedented transparency into global loan level details and lender portfolio positions, bringing efficiency and velocity to the entire asset class. Through its centralized platform, participants can rest assured they are accessing the loan market’s most credible source of deal information. With the support of its investors, Versana has become the data provider of choice to usher in the long-awaited modernization of the $9 trillion loan market. For more information, visit versana.io.

Media Contact
Forefront Communications
[email protected] 

SOURCE Versana

Financing Supported by Leading Strategic and Institutional Investors to Accelerate Critical Mineral Processing & Domestic Uranium Recovery

CASPER, Wyo., Apr. 30, 2026 — DISA Technologies Inc. (DISA), a company pioneering high-impact solutions for mineral processing, domestic uranium remediation and resource recovery, has closed a $33 million strategic financing led by Galvanize and supported by BHP Ventures.

“This financing marks a key milestone in DISA’s growth as a platform for critical mineral processing and domestic uranium remediation,” said Greyson Buckingham, CEO and Co-Founder of DISA. “With the support of Galvanize, BHP Ventures, and our existing investors, we are accelerating commercialization and scaling deployment of our technology to meet a growing national need.”

“Critical minerals are a foundational constraint on both energy security and industrial competitiveness,” said Cliff Ryan, Co-Head of Venture and Growth at Galvanize. “DISA’s technology stands out for its ability to unlock value from both existing operations and legacy assets, and to do so with speed and efficiency. We’re excited to support the team as they scale deployment.”

“DISA Technologies’ HPSA approach to processing critical minerals across mining and remediation sites is designed for broad deployment,” said Laurel Buckner, VP of New Business Ventures at BHP. “As operating costs increase across the supply chain and global demand continues to grow, we see the opportunity for critical minerals recovery to unlock future value.”

Key existing investors including Evok Innovations, Constellation Energy, Halliburton Labs, Valor Equity Partners, and Veriten continued their participation in the round. With this financing, DISA has raised approximately $83 million to date, backed by a diverse group of strategic and institutional investors with deep experience across mining, energy, and industrial technology. DISA’s patented High-Pressure Slurry Ablation (HPSA™) technology is designed to unlock value across both modern mineral processing and legacy uranium remediation, delivering a cleaner, faster, and more efficient method to liberate minerals.

The company is scaling deployment across mining operations and Abandoned Uranium Mine (AUM) remediation projects, with commercial units installed at several global sites and over 100 AUM sites secured under contract to date.

In September 2025, DISA was issued a first-of-its-kind NRC license, enabling access to remediate AUM sites across the nation. The company expects to commence remediation projects later this year, including on the Navajo Nation and at a federal site under its NRC license.

The participation of both new and existing investors underscores strong alignment around DISA’s strategy to address critical mineral supply chain challenges and unlock value from legacy uranium assets. Insider participation from Evok, Constellation Energy, Halliburton Labs, Valor Equity Partners, and Veriten reflects continued conviction in DISA’s growth trajectory and technology platform.

DISA has achieved significant technical and commercial milestones over the past 12 months, including advancing regulatory pathways, adding multiple strategic investors, commissioning commercial-scale HPSA™ units across multiple mining applications, and continuing to scale its uranium remediation and recovery platform.

For more information about DISA and its solutions, please visit www.disatech.com.

About DISA Technologies

Founded in 2018, DISA Technologies is revolutionizing mineral recovery with our patented High-Pressure Slurry Ablation (HPSA™) technology—an innovative solution that upgrades critical minerals from mined ore and legacy waste. Serving both the mining and remediation sectors, we recover valuable resources that power industry, strengthen energy independence and restore contaminated sites to productive use. DISA’s technology unlocks economic and environmental value, transforming how the world processes, remediates and recycles essential mineral assets. DISA is headquartered inCasper, Wyoming, with a satellite office in Westminster, Colorado.

About Galvanize

Galvanize is a global asset manager investing at the intersection of energy innovation, resilience, and intelligence. The firm deploys capital across seed, venture, growth, public equities, credit, and real estate, combining investment expertise with deep in-house capabilities in technology, policy, and markets. Galvanize is structured to rapidly identify and execute on investment opportunities created by the energy transition, across all sectors of the economy.

About BHP Ventures

BHP Ventures is the in-house venture capital arm of BHP Group Limited. The fund invests in breakthrough technologies, shaping the future of BHP and the global resources industry. BHP Ventures complements the innovation already underway within BHP by enabling new partnerships and creating opportunities to strengthen the company’s portfolio and lower emissions. BHP is a global resources company that produces essential commodities the world needs, including iron ore, copper, steelmaking coal – and soon potash. With operations and projects in over 90 countries around the world, BHP is the world’s largest copper producer.

SOURCE DISA Technologies, Inc.

Firm backs enduring tech leaders – including Anduril, Gusto, Ramp, SpaceX – through longer private lifecycles

SAN FRANCISCO, April 30, 2026 — 137 Ventures, a growth-stage venture firm backing companies including Anduril, Gusto, Ramp and SpaceX, today announced the close of over $700 million across two new funds, bringing total assets under management to more than $15 billion. The raise marks a significant step in the continued scaling of 137 Ventures’ platform, designed to invest in technology companies with the potential for significant market impact across their entire growth lifecycle.

“137 invests in category-defining technology companies with the potential to become enduring long-term compounders and market leaders,” said Justin Fishner-Wolfson, Founder and Managing Partner at 137 Ventures. “The next generation of iconic companies will take shape over longer time horizons and with greater complexity. Supporting them requires a different kind of capital – more flexible and designed for decades. That’s what we’re building at 137.”

Over the past 12 months, 137 Ventures has deployed more than $1.7 billion, continuing to concentrate capital in select opportunities. Recent investments include Cognition, Impulse Space, Hadrian, and Physical Intelligence – companies operating at the frontier of AI, defense, and advanced industrial systems.

Alongside its platform expansion, 137 Ventures continues to invest in its team and capabilities. Recent additions and promotions include:

• Ashley Steinberg, Head of Strategic Initiatives (formerly of The Boring Company)
• Lindsay Searer, Head of Fund Strategies (formerly of Pathstone)
• James Pardee, Partner (promotion)

Fishner-Wolfson continued, “As we’ve scaled the platform, we’ve been equally focused on building the team and capabilities required to support it. This fund reflects not just the opportunity we see in the market, but the people we’ve brought together to execute on it – combining deep investment experience with the flexibility to structure solutions that meet companies where they are.”

ABOUT 137 VENTURES

137 Ventures is a growth-stage venture capital firm that partners with generational technology companies and their founders across their entire growth lifecycle. Justin Fishner-Wolfson and S. Alexander Jacobson started 137 Ventures in 2010 after meeting at Founders Fund. Since its inception, the firm has raised nine institutional funds and several other dedicated investment strategies and vehicles, bringing total assets under management to over $15 billion as of March 2026. More about 137 Ventures, including a list of its portfolio companies, can be found on its website.

SOURCE 137 Ventures

ABU DHABI, UAE, April 30, 2026 — Hashed Global Management Limited (HGML), an entity within the Hashed global venture capital group (“the Group”, “Hashed”), has obtained a Financial Services Permission (FSP) from the Financial Services Regulatory Authority (FSRA) of ADGM, the international financial centre of Abu Dhabi.

With this permission, HGML is authorized to conduct regulated financial activities in or from ADGM, including advising on investments or credits, arranging investment deals, managing assets, and collective investment funds.

ADGM recognition for its progressive regulatory framework in fintech, digital assets, and emerging financial technologies. Leveraging this, the Group plans to position ADGM as its official base for institutional operations across the UAE/GCC region, strengthening connections between its global capital network and local institutional investors.

Through ADGM, Hashed plans to strengthen its role as a strategic bridge between the UAE/GCC and innovation networks anchored in Korea and Asia. It will deepen investment connectivity, expand cross-border partnerships, and support long-term collaboration between regional capital and globally connected founders and ecosystems.

Simon Kim, CEO of Hashed,  stated, “Abu Dhabi is a city at the forefront of global digital financial infrastructure. Establishing an official business foundation under ADGM’s regulatory framework reflects Hashed’s commitment to building a trust-based business in this region for the long term.”

Seokwon Hong, Licensed Director and Senior Executive Officer at HGML , added, “This permission lays the groundwork for HGML to collaborate with Middle Eastern institutional investors within a regulated environment. Through our partnership with ADGM, we will work together to help shape both policy and the market.”

Arvind Ramamurthy, Chief Market Development Officer at ADGM , said, “We congratulate HGML on receiving its FSP. This milestone underscores the growing momentum we are seeing as leading firms choose ADGM and Abu Dhabi to establish and scale their regional operations. ADGM remains committed to providing a trusted, forward-looking regulatory environment and a world-class ecosystem that supports innovation, strengthens cross-border connectivity, and enables long-term growth.”

Hashed co-hosted the “Web3 Leaders Roundtable” with ADGM during Abu Dhabi Finance Week (ADFW) 2025, focusing on the convergence of AI and blockchain-based financial infrastructure. Discussions covered blockchain’s role as AI-native infrastructure, the tokenisation-driven transformations, and regulatory considerations for institutional investors. Participants included ADIA, DTCC, Franklin Templeton, BlackRock, Circle, Consensys, and the Solana Foundation, and the outcomes of the discussion were published as a policy report.

SOURCE Hashed Global Management Limited (HGML)

Led by Healthier Capital, the funding will accelerate Photon‘s mission to modernize the prescription experience, putting patients in the driver’s seat at the moment that matters most.

BROOKLYN, N.Y., April 30, 2026 — Electronic prescribing transformed how doctors write prescriptions, but created a new problem for patients. At the moment a prescription is written, patients are asked to choose a pharmacy on the spot with no pricing, no inventory information, and no sense of what’s convenient or covered. The prescription is sent, the moment passes, and a choice has been made without the information needed to make it well. The result: transfers, phone calls, and delays that create unnecessary burden for patients, pharmacies, and practitioners alike. Photon was built to solve this at the source.

Photon today announced a $16M Series A round led by Healthier Capital, with participation from Notation, Flare Capital, and Evidenced. The funding will be used to expand the engineering and commercial teams, drive expanded health system and platform integrations, and accelerate the company’s mission to become the default infrastructure for modern prescribing and medication access.

The problem runs deeper than consumer inconvenience. It’s an infrastructure problem rooted in an era before smartphones, the cloud, or AI. Electronic prescribing was designed in the early 2000s to move prescriptions from point A to point B — and it does. But it was never designed to inform patients, serve the expectations of modern prescribers, or keep pace with how pharmacies actually operate today. In virtually every other aspect of their lives, consumers expect real-time transparency: they can see pricing, availability, and delivery windows before they buy anything. The prescription experience offers none of that. When a prescription is sent electronically, the patient is effectively removed from the equation — no visibility into which pharmacy has it in stock, what it will cost out of pocket, or which option is most convenient. That information vacuum sets off a downstream chain of friction: unnecessary transfers, unanswered phone calls, abandoned fills, and administrative burden that ripples across the entire healthcare ecosystem.

Photon is rebuilding the prescription experience from the ground up, not as a pricing widget or a single-point fix, but as a full end-to-end platform. That means:

• Modern prescribing and routing infrastructure
• A network of pharmacy partners across retail and home delivery
• A consumer-facing marketplace that surfaces real-time price and stock information
• A full suite of capabilities including prior authorization, clinical decision support, and beyond

By integrating at the point of prescribing, Photon gives patients the ability to make an informed choice before the prescription is ever sent. The kind of transparency consumers take for granted everywhere else, finally applied to one of the most consequential moments in their healthcare journey. For health systems, that same platform unlocks something equally valuable: the prescription becomes a patient engagement touchpoint rather than a handoff, in-house pharmacy teams gain real-time visibility into fill activity, and patients can be educated about delivery options and price competitiveness in real time. Artificial intelligence is central to how Photon does this at scale, processing complex, fragmented data across pharmacy networks, benefit structures, and formularies in real time, and translating it into something a patient can actually use. This is not AI as a marketing feature; it’s AI as the engine that makes a genuinely hard infrastructure problem solvable. The result is fewer abandoned prescriptions, fewer reroutes, and a meaningfully better experience for every stakeholder in the chain.

“We’re building prescription infrastructure for the AI era. We’re scaling at a critical juncture where healthcare SaaS and services are being disrupted by LLMs and agentic workflows — right as healthcare affordability and consumer demand for transparency reach a boiling point. We’re leveraging this technology to empower consumers, enable true price transparency, and push the pharmacy industry back toward an open marketplace,” says Otto Sipe, Photon founder and CEO.

“We are delighted to partner with Photon to modernize the prescription process, delivering an improved experience for patients while reducing friction across the entire healthcare system,” said Amir Dan Rubin, Founder & Managing Partner, Healthier Capital.

Photon got its start in direct-to-consumer digital health, building the prescription infrastructure that powers some of the fastest-growing D2C health brands. That foundation — deep integrations across pharmacy networks, real-time formulary data, and a patient-first prescribing experience — proved equally compelling to health systems, where Photon has been growing its presence as those organizations seek better ways to engage patients at the point of care and drive visibility into their in-house pharmacies. Since its founding in 2021, Photon has helped millions of patients make more informed pharmacy decisions. The company’s last fundraise was $9M in July 2024. This round positions Photon to deepen marketplace integrations, expand health system partnerships, and help more consumers take ownership of their prescriptions.

The ambition extends well beyond a single prescribing moment. Photon is building long-term infrastructure designed to ease systemic burden across the healthcare system — for practitioners who shouldn’t have to field reroute calls, for pharmacies drowning in unnecessary transfers, for health systems that want prescriptions to drive patient retention and in-house pharmacy utilization rather than quietly leak volume elsewhere, and for patients who deserve to be informed participants in their own care. AI accelerates that roadmap in a meaningful way: enabling Photon to identify patterns across the system, anticipate points of friction before they occur, and build toward solutions that address the structural conditions causing problems, not just their symptoms.

About Photon Photon is the end-to-end prescription infrastructure built for modern healthcare. Combining proprietary digital prescribing and routing infrastructure, a vast pharmacy network, and a consumer-facing marketplace, Photon brings real-time transparency to the moment a prescription is written, so patients can make an informed choice before it is ever sent. For health systems and providers, Photon reduces administrative burden, supports prior authorization and patient support workflows, and turns the prescribing moment into a driver of patient engagement and in-house pharmacy utilization. By modernizing the infrastructure that connects prescribers, pharmacies, and patients, Photon improves medication access and adherence across the entire care journey. Learn more at photonhealth.com.

About Healthier Capital Healthier Capital seeks to advance healthier outcomes for all, partnering with technology-powered healthcare innovators for transformative impact and significant value creation. For more information, visit www.healthiercapital.com.

SOURCE Photon Health

Option exercise triggers $25M payment to Pinetree.

CAMBRIDGE, Mass., April 29, 2026 — Pinetree Therapeutics, Inc. (“Pinetree”), a biotechnology company pioneering next-generation targeted protein degradation approaches for cancer and other serious diseases, today announced that AstraZeneca (LSE/STO/NYSE: AZN) has exercised its option under the companies’ previously announced agreement to obtain an exclusive global license to develop and commercialize PTX-299, a first-in-class bispecific antibody degrader targeting EGFR.

The option exercise follows encouraging preclinical progress and represents an important milestone in the collaboration between the two companies. Under the terms of the agreement, AstraZeneca will assume responsibility for global development and commercialization of the therapeutic candidate.

“This milestone marks an important validation of our AbReptor™ platform,” said Hojuhn Song, Ph.D., Founder and CEO of Pinetree Therapeutics. “We are pleased that AstraZeneca has exercised its option to advance PTX-299, and we look forward to seeing them continue the development of this promising therapeutic candidate. By combining Pinetree’s breakthrough protein degradation platform with AstraZeneca’s global expertise in cancer drug development, we believe that PTX-299 has the potential to bring a meaningful new treatment option to patients with EGFR-driven cancers.”

EGFR plays a critical role in the growth and survival of cells in multiple tumor types. While EGFR-targeted therapies have transformed patient outcomes, resistance can develop, highlighting the need for new therapeutic strategies. By leveraging Pinetree’s antibody-based protein degradation technology, PTX-299 is designed to selectively eliminate disease-driving EGFR proteins rather than simply inhibiting their activity, potentially overcoming key resistance mechanisms.

The therapeutic candidate was developed using AbReptor™, Pinetree’s proprietary multispecific antibody-based targeted protein degradation platform. In contrast to conventional monoclonal antibodies that rely on functional inhibition, AbReptor™ drives the active removal of disease-associated proteins through targeted degradation. By enabling the elimination of membrane-bound and extracellular targets, this platform extends beyond the limitations of traditional inhibition-based antibody therapies.

Under the terms of the agreement, AstraZeneca’s exercise of the option triggers a $25 million option closing payment to Pinetree. Pinetree is also eligible to receive potential future development, regulatory, and commercial milestone payments and tiered royalties on global net sales if the product is successfully developed and commercialized. The total potential value of the agreement exceeds $500 million.

About Pinetree Therapeutics
Pinetree Therapeutics, based in Cambridge, MA, is a preclinical-stage biotech company developing next-generation targeted protein degraders (TPDs) to overcome drug resistance and tumor recurrence in oncology, with applications in inflammation and immunology. Its proprietary AbReptor™ platform enables selective degradation of membrane-bound and extracellular proteins, offering a differentiated mechanism of action and durable therapeutic benefit. Pinetree is also advancing trispecific degraders and ADC-integrated platforms.

For more information, visit https://www.pinetreetx.com/.

Contact:
Zachary Park
[email protected]

SOURCE PineTree Therapeutics

– Reforzando su estrategia de finanzas sostenibles, PT Vale obtiene una línea de crédito sindicada vinculada a criterios ESG por valor de 750 millones de dólares

YAKARTA, Indonesia, 29 de abril de 2026 — PT Vale Indonesia Tbk (“PT Vale” o la “Compañía”) ha obtenido un préstamo vinculado a la sostenibilidad (SLL) de 750 millones de dólares, que incluye una opción de sobreasignación de 250 millones de dólares, lo que marca su debut en el mercado de préstamos sindicados y refuerza su estrategia de financiación sostenible. Respaldado por 14 bancos internacionales y con una sobredemanda de 1,7 veces, este préstamo refleja la gran confianza de los prestamistas en el perfil crediticio de PT Vale, su cartera de proyectos estratégicos y su trayectoria de crecimiento vinculada a criterios ESG.

Estructurado bajo el Marco de Financiamiento Vinculado a la Sostenibilidad de PT Vale, el financiamiento está vinculado a dos indicadores clave de rendimiento: la reducción de la intensidad de las emisiones de carbono y el aumento del consumo de energía renovable. Ambos indicadores recibieron una calificación de “sólida” por parte de un proveedor independiente de Opinión de Segunda Parte, en consonancia con la trayectoria de 1,5 °C del Acuerdo de París y las Contribuciones Determinadas a Nivel Nacional de Indonesia.

A medida que crece la demanda de níquel producido de manera responsable, impulsada por la electrificación, el almacenamiento de energía y la descarbonización global, PT Vale se posiciona como un productor con emisiones de carbono relativamente bajas, respaldado por operaciones basadas en energía hidroeléctrica.

Bernardus Irmanto, presidente director y consejero delegado de PT Vale, declaró: “Esta operación representa un paso importante en nuestro camino para alinear nuestra estrategia financiera con nuestra agenda de descarbonización y nuestras ambiciones de crecimiento a largo plazo. Mantenemos nuestro compromiso de ofrecer níquel de alta calidad con una menor huella de carbono, al tiempo que apoyamos la agenda de transformación de Indonesia y contribuimos significativamente a la transición energética global”.

Harapman Kasan, director de Banca Mayorista de UOB Indonesia, afirmó: “A medida que el sector del níquel en el sudeste asiático continúa evolucionando, el papel de una financiación de transición bien estructurada se vuelve cada vez más crucial. Esta transacción refleja nuestro compromiso de alinear las estructuras financieras con objetivos de sostenibilidad medibles, al tiempo que apoyamos las prioridades más amplias de Indonesia en materia de transición industrial y energética”.

Mike Zhang, director global de Metales y Minería de Banca Institucional en DBS Bank, añadió que el sector de metales y minería desempeña un papel fundamental en la transición energética y debe demostrar un progreso creíble y medible en materia de sostenibilidad.

Ken Matsuo, presidente director de PT Bank Mizuho Indonesia, comentó: “El sector energético es un pilar de la economía indonesia, y nos complace apoyar el primer préstamo sindicado de PT Vale. A pesar de la volatilidad del mercado, la fuerte participación y la sobredemanda demuestran la confianza en el modelo de negocio de PT Vale. Consideramos que la integración de criterios ESG en estructuras de financiación como esta es un factor clave para una transición energética sostenible”.

PT Vale también destinará los beneficios financieros derivados de los ajustes de margen vinculados a la sostenibilidad a programas de desarrollo comunitario, extendiendo así el impacto ESG más allá de las operaciones.

Contacto para medios:
Vanda Kusumaningrum 
Responsable de Comunicaciones Corporativas
PT Vale Indonesia Tbk.
[email protected]

Foto – https://mma.prnewswire.com/media/2968703/WhatsApp_Image_2026_04_24_at_15_12_57.jpg

• New Rocsys M1 enables hands-free, multi-bay charging for robotaxi fleets, the first solution in a broader platform built for real-world deployment, validated by a major robotaxi deal and set for rollout across North America and Europe in 2027
• The overhead rail-mounted system works across mixed EV fleets and any charger type, maximizing parking space and enabling uninterrupted, safe operation with up to 75% productivity increase from existing staff
• In conjunction with the release of the M1, Rocsys has also raised a $13M Series A extension, backed by leading investors including Capricorn Partners and Scania Invest

RIJSWIJK, Netherlands and PORTLAND, Ore., April 29, 2026 — Rocsys, the global leader in hands-free depot solutions for autonomous electric vehicles, today announced the Rocsys M1—the world’s first hands-free charging solution capable of serving multiple bays in robotaxi operations. Part of a broader depot service platform that enables full depot autonomy, the M1 is currently in pilot deployment, with large-scale rollout set to begin in 2027. Rocsys plans to support thousands of charging bays across North America and Europe over the next five years.

To support this expansion, Rocsys also announced a $13M Series A extension led by Capricorn Partners, with participation from Scania Invest, Forward.One, SEB Greentech Venture Capital and Graduate Ventures, bringing total funding raised to date to $56M.

The global robotaxi market is projected to reach $45.7B by 2030, driving rapid fleet expansion and increasing the intensity of depot operations. As utilization rises, existing infrastructure is pushed to its limits, with manual charging emerging as a critical barrier to operational continuity. Repeated thousands of times each day, charging processes introduce cost, operational friction and safety risks, becoming a structural constraint on fleet growth and profitability.

Rocsys addresses this gap by enabling fleet readiness, transforming charging into an automated process that maximizes uptime and boosts productivity.

The M1’s modular, multi-bay architecture allows a single system to seamlessly serve multiple vehicles across up to 10 bays, increasing throughput while reducing operational costs. Flexible overhead mounting options, including ground- and roof-mounted configurations, integrate with virtually any depot layout, preserve full depot space and allow parallel activities such as cleaning and inspection during charging. At scale, in a depot with 50 parking bays, the Rocsys M1 can deliver up to 75% higher operational efficiency from existing staff and bring up to $1.7 million in annual savings.

Built on a platform proven in active port operations and other high-duty environments and trained on more than six years of real-world data and edge cases, the Rocsys M1 adapts to variations in lighting, weather and vehicle positioning, achieving consistent, predictable performance and delivering 99.9%+ plug-in success rate in live environments. At its core, the Rocsys M1 combines AI-enhanced computer vision for precise, continuously improving plug-in performance and motion intelligence for safe, context-aware operation. This is underpinned by Rocsys’ broader technology, backed by 130+ granted patents and pending applications.

Rocsys M1 is fully interoperable across EVs, chargers and connector types. An overhead rail-mounted design with a flexible, long-reach robotic arm enables reliable connection and disconnection across mixed fleets, regardless of charging inlets position, allowing immediate deployment without costly retrofitting or lock-in.

You can see the M1 in action here, while a visualization will be showcased at Rocsys’ booth 3401 at ACT Expo (4–6 May) in Las Vegas.

As part of the Rocsys Platform, the M1 integrates hardware, software and services to support autonomous fleet operations. It operates within a connected service ecosystem that combines the Rocsys Portal for operational visibility, APIs for integration with customer IT systems and remote monitoring with expert field support. Working quietly in the background, these services ensure vehicles remain charged and ready when needed.

Crijn Bouman, CEO and Co-Founder of Rocsys, said: “Autonomous vehicles are growing rapidly, and infrastructure must keep pace. Without hands-free operations, autonomy stops at the depot. Based on a platform designed to extend beyond charging to automated interior cleaning and inspection, the Rocsys M1 introduces smart charging infrastructure for continuous, real-world use at scale, validated by signing a major robotaxi deal. It enables operators to run mixed fleets autonomously, reliably and without interruption. This is the missing link for robotaxi operators to move from pilots to global deployment.”

Steven Lambert from Capricorn Partners added: “Robotaxis are entering an acceleration phase, where operational scaling becomes the defining challenge. Infrastructure will determine how quickly and efficiently this transition happens. Rocsys is building the system layer required to support that shift, with proven, purpose-built technology already operating in demanding environments. At Capricorn Partners, we are keen to enable Rocsys’ growth to bring the foundation for the future of autonomous mobility.”

Johannes Fors Källström from Scania Invest, said: “At Scania Invest, our mission is to support companies driving the transition to a more sustainable transport system. Rocsys technology addresses a key infrastructure bottleneck for the broader deployment of autonomous vehicles. With several years of operational experience, Rocsys has demonstrated a strong focus on reliability, a critical factor for maximizing uptime in real-world operations. Their technical depth and growing operational track record position them well within this emerging segment of autonomous vehicle servicing.”

About Rocsys

Rocsys is the global leader in hands-free charging and fleet service solutions for electric and autonomous vehicles. The company’s cutting-edge technology, including next-generation soft robotics, AI-driven computer vision, and data-driven proactive services, unlocks greater efficiency, safety, and scalability for the world’s leading ports operators, distribution companies and robotaxis. With operations in Europe and the United States, Rocsys plays a leading role in shaping standards that will unify a powerful EV ecosystem through industry consortiums and strategic partnerships with multinational corporations and OEMs. For more information, visit www.rocsys.com.

About Capricorn Partners

Capricorn Partners is an independent European manager of venture capital funds investing in innovative European companies with technology as competitive advantage in the areas of digital, health and cleantech. Through our experienced team of engineers, scientists, financial experts and former entrepreneurs, we actively support and guide promising founders in their growth journey. Capricorn Partners is also the management company of the public privak Quest for Growth, quoted on Euronext Brussels. See www.capricorn.be for more information.

About Scania Invest

Scania Invest is Scania’s in-house, global venture capital arm, investing across all stages. We invest across four focus sectors; energy & infrastructure, autonomous & supply chain, asset management & circularity, and deep tech. We provide more than just capital to our portfolio companies – by leveraging Scania’s core capabilities, we drive value and serve as long-term partners to our portfolio companies.

Photo: https://mma.prnewswire.com/media/2969003/Rocsys.jpg
Logo:  https://mma.prnewswire.com/media/2969002/Rocsys_Logo.jpg

SOURCE Rocsys

NEW YORK, April 29, 2026 — Squads today announced an $18 million strategic round led by Solana Ventures, with participation from Coinbase Ventures, Haun Ventures, L1D, Collab+Currency, Electric Capital, Placeholder, Jump Crypto, and Robot Ventures, bringing total funding to $42.9M. This raise accelerates Altitude, a financial operating system built on stablecoin infrastructure.

Stablecoins are changing the infrastructure of business finance. For the last decade, building financial products for businesses meant building on top of banks – bank partnerships were required to hold customer funds and access payment rails. Every new market meant a new bank and a new compliance cycle. Blockchains changed the underlying infrastructure. Stablecoins turned money into software, allowing treasury and payments to be separated from the fractional reserve system for the first time.

This separation has produced a new category of licensed Payment Service Providers (PSPs) that move money across both stablecoin and traditional banking rails. The market has moved quickly: Stripe acquired Bridge for $1.1 billion, Mastercard acquired BVNK for $1.8 billion. These PSPs were the missing piece to build a full-stack financial operations platform on stablecoin rails.

Altitude is built on this shift. It does not hold customer funds. Treasury is held in stablecoins. When funds need to move, they settle on stablecoin rails instantly, 24/7, at low cost. When they need to reach traditional banking rails, they do so through a network of licensed stablecoin PSPs.

Since publicly launching in December 2025, Altitude has processed over $200 million in payments for exporters, global agencies, crypto-native companies, and cross-border remote teams. Customers choose Altitude for what stablecoin infrastructure unlocks: global-by-default coverage, multi-currency support, instant settlement, and programmable controls. With $18M in new funding, Altitude is growing its team, expanding its payment network, and accelerating product development.

“This raise backs a simple idea: businesses are better off running on stablecoins than on legacy banking infrastructure. Solana is now mature enough to carry global business finance, regulators have built the frameworks to support it, and for the first time you can build a full financial platform on a genuinely new system,” said Stepan Simkin, CEO of Squads.

“The Squads team spent the last four years building the security infrastructure that most of the Solana ecosystem runs on. Stablecoins and programmable blockchains are changing how global finance works. This is the team with the technical depth and the vision to build the financial platform that sits on top of that shift. We believe Altitude will be how the next generation of global businesses runs their financial operations,” said Matthew Beck, Head of Solana Ventures.

Two criticisms have historically limited stablecoin adoption in mainstream business finance: compliance gaps and security concerns. Altitude addresses both directly.

On compliance, Altitude has built a proprietary engine that imposes the same checks expected from any regulated fintech: continuous sanctions screening, AML checks, transaction monitoring, and KYB verification. This engine enables every Altitude account to plug into licensed PSPs including Bridge, MoonPay, Infinite, Due, and others for global coverage.

On security, Altitude enforces controls at each layer of the stack. At the product layer, every business account comes with programmable controls, granular permissions, and configurable multifactor authentication. At the infrastructure layer, Squads Protocol handles asset custody and money movement, securing over $10 billion in value. At the settlement layer, every transaction is recorded and settled on Solana.

“As we scaled, treasury and payments turned into an operational headache. Complexity and fees kept compounding. Altitude removed both,” said Kash Dhanda, COO, Jupiter.

About Squads

Squads is a financial infrastructure company building on Solana. The company operates two products: Squads Multisig, the smart account standard securing over $10 billion in assets across the Solana ecosystem, and Altitude, a financial operating system that gives businesses multi-currency accounts, corporate cards, global payments, APY on balances, and a CFO stack to run it all. Learn more at altitude.xyz or squads.xyz.

SOURCE Squads